These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12055587)

  • 41. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.
    Achiwa H; Yatabe Y; Hida T; Kuroishi T; Kozaki K; Nakamura S; Ogawa M; Sugiura T; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1999 May; 5(5):1001-5. PubMed ID: 10353732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Holden J; Davis M; Zempolich K; Murphy KJ; Dodson M
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1213-7. PubMed ID: 11286825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma.
    Chen CN; Sung CT; Lin MT; Lee PH; Chang KJ
    Ann Surg; 2001 Feb; 233(2):183-8. PubMed ID: 11176123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
    Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
    Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.
    von Rahden BH; Stein HJ; Pühringer F; Koch I; Langer R; Piontek G; Siewert JR; Höfler H; Sarbia M
    Cancer Res; 2005 Jun; 65(12):5038-44. PubMed ID: 15958546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.
    Lagorce-Pagès C; Paraf F; Wendum D; Martin A; Fléjou JF
    Virchows Arch; 2004 May; 444(5):426-35. PubMed ID: 15045585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells.
    Abdalla SI; Sanderson IR; Fitzgerald RC
    Carcinogenesis; 2005 Sep; 26(9):1627-33. PubMed ID: 15878911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical analysis of cyclooxygenase-2 expression in premalignant and malignant esophageal glandular and squamous lesions in Cixian, China.
    Zhang W; Wang L; Chang A; Jin Y; Rao J
    Cancer Detect Prev; 2003; 27(4):243-9. PubMed ID: 12893070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The clinical strategy for the Barrett's esophagus].
    Kitabatake S; Niwa Y; Goto H
    Nihon Rinsho; 2005 Aug; 63(8):1434-7. PubMed ID: 16101235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
    Gupta RA; DuBois RN
    J Natl Cancer Inst; 2002 Mar; 94(6):406-7. PubMed ID: 11904306
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.
    Wu AW; Gu J; Ji JF; Li ZF; Xu GW
    World J Gastroenterol; 2003 Sep; 9(9):1990-4. PubMed ID: 12970891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.
    Lim HY; Joo HJ; Choi JH; Yi JW; Yang MS; Cho DY; Kim HS; Nam DK; Lee KB; Kim HC
    Clin Cancer Res; 2000 Feb; 6(2):519-25. PubMed ID: 10690533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of adenocarcinoma among patients with Barrett's esophagus.
    Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
    N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux.
    Jang TJ; Min SK; Bae JD; Jung KH; Lee JI; Kim JR; Ahn WS
    Gut; 2004 Jan; 53(1):27-33. PubMed ID: 14684572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of cyclooxygenase-2 in human lung carcinoma.
    Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A
    Cancer Res; 1998 Nov; 58(22):4997-5001. PubMed ID: 9823297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.